2015
Folic acid supplementation in early pregnancy and the risk of preeclampsia, small for gestational age offspring and preterm delivery
Martinussen MP, Bracken MB, Triche EW, Jacobsen GW, Risnes KR. Folic acid supplementation in early pregnancy and the risk of preeclampsia, small for gestational age offspring and preterm delivery. European Journal Of Obstetrics & Gynecology And Reproductive Biology 2015, 195: 94-99. PMID: 26500184, PMCID: PMC4684439, DOI: 10.1016/j.ejogrb.2015.09.022.Peer-Reviewed Original ResearchMeSH KeywordsAdultCohort StudiesFemaleFolic AcidHumansInfant, Low Birth WeightInfant, NewbornInfant, Small for Gestational AgeObesityOdds RatioPre-EclampsiaPregnancyPregnancy ComplicationsPregnancy Trimester, FirstPremature BirthProspective StudiesProtective FactorsRisk FactorsVitamin B ComplexYoung AdultConceptsFolic acid supplementationLow birth weightFolic acid intakePreterm birthAcid supplementationFirst trimesterLean mothersBirth weightAcid intakeEarly pregnancyOdds ratioGestational age offspringProspective cohort studyFolic acid supplementsFolic acid usePregnancy outcome dataRisk of preeclampsiaPossible protective effectMonths of pregnancyObese mothersPreterm deliveryCohort studyObstetric recordsAge offspringFolate intake
2013
Genome‐Wide Association Study of Pre‐Eclampsia Detects Novel Maternal Single Nucleotide Polymorphisms and Copy‐Number Variants in Subsets of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cohort
Zhao L, Bracken MB, DeWan AT. Genome‐Wide Association Study of Pre‐Eclampsia Detects Novel Maternal Single Nucleotide Polymorphisms and Copy‐Number Variants in Subsets of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cohort. Annals Of Human Genetics 2013, 77: 277-287. PMID: 23551011, PMCID: PMC3740040, DOI: 10.1111/ahg.12021.Peer-Reviewed Original ResearchConceptsCopy number variantsSingle nucleotide polymorphismsAssociation studiesGenome-wide SNP dataMaternal single nucleotide polymorphismsGenome-wide association studiesTop single nucleotide polymorphismsNucleotide polymorphismsWide association studyEuropean ancestry subjectsCandidate genetic variantsSNP dataBeadChip microarrayGenetic variantsCase-control datasetEuropean ancestryCandidate copy-number variantsIllumina Human610-QuadCNV findingsPolymorphismVariants
2012
Association between the SERPINE1 (PAI-1) 4G/5G insertion/deletion promoter polymorphism (rs1799889) and pre-eclampsia: a systematic review and meta-analysis
Zhao L, Bracken MB, Dewan AT, Chen S. Association between the SERPINE1 (PAI-1) 4G/5G insertion/deletion promoter polymorphism (rs1799889) and pre-eclampsia: a systematic review and meta-analysis. Molecular Human Reproduction 2012, 19: 136-143. PMID: 23180602, DOI: 10.1093/molehr/gas056.Peer-Reviewed Original Research
2000
Abortion and Its Effect on Risk of Preeclampsia and Transient Hypertension
Eras J, Saftlas A, Triche E, Hsu C, Risch H, Bracken M. Abortion and Its Effect on Risk of Preeclampsia and Transient Hypertension. Epidemiology 2000, 11: 36-43. PMID: 10615841, DOI: 10.1097/00001648-200001000-00009.Peer-Reviewed Original ResearchConceptsRisk of preeclampsiaTransient hypertensionNulliparous womenDecreased riskMore abortionsPregnancy-related risk factorsHistory of abortionHypertensive disordersWeeks' gestationGestational ageSubsequent pregnancyPrenatal careRisk factorsObstetric practicePrior abortionMonths gestationPreeclampsiaHypertensionInduced abortionReproductive historyReferent groupProtective factorsGestationWomenAbortion
1989
LOG-LINEAR MODELS FOR THE ANALYSIS OF MATCHED COHORT STUDIES
HOLFORD T, BRACKEN M, ESKENAZ B. LOG-LINEAR MODELS FOR THE ANALYSIS OF MATCHED COHORT STUDIES. American Journal Of Epidemiology 1989, 130: 1247-1253. PMID: 2589315, DOI: 10.1093/oxfordjournals.aje.a115453.Peer-Reviewed Original Research
1988
Exposure to Organic Solvents and Hypertensive Disorders of Pregnancy
Eskenazi B, Bracken M, Holford T, Grady J. Exposure to Organic Solvents and Hypertensive Disorders of Pregnancy. American Journal Of Industrial Medicine 1988, 14: 177-188. PMID: 3207103, DOI: 10.1002/ajim.4700140208.Peer-Reviewed Original ResearchConceptsHypertensive disordersPregnancy complicationsAdverse pregnancy complicationsDisorders of pregnancyPoor neonatal growthNeed of replicationCardiovascular complicationsVaginal bleedingCesarean sectionRenal diseaseGlomerular lesionsNeonatal growthComplicationsLarger sample sizePregnancySolvent exposureWomenHypertensionPreeclampsiaProteinuriaDisordersEdemaExposureSample sizeAdditional support
1986
Proportional weight gain and complications of pregnancy, labor, and delivery in healthy women of normal prepregnant stature
Shepard M, Hellenbrand K, Bracken M. Proportional weight gain and complications of pregnancy, labor, and delivery in healthy women of normal prepregnant stature. American Journal Of Obstetrics And Gynecology 1986, 155: 947-954. PMID: 3619994, DOI: 10.1016/0002-9378(86)90323-6.Peer-Reviewed Original ResearchConceptsComplications of pregnancyProlonged second stageProportional weight gainWeight gainMultigravid womenHealthy womenYale-New Haven HospitalEarly prenatal visitPreexisting chronic diseaseAdverse neonatal outcomesMajor congenital malformationsSignificant risk factorsDays of deliveryHealth maintenance organizationGestational hypertensionPrepregnant weightNeonatal outcomesCesarean sectionFourfold riskPrenatal visitPrimigravid womenHospital clinicQuetelet indexRisk factorsChronic diseases
1982
Oral contraception as a risk factor for preeclampsia
Bracken M, Srisuphan W. Oral contraception as a risk factor for preeclampsia. American Journal Of Obstetrics And Gynecology 1982, 142: 191-196. PMID: 7055184, DOI: 10.1016/s0002-9378(16)32335-3.Peer-Reviewed Original ResearchMeSH KeywordsAdultBlood PressureBody WeightContraceptives, OralFemaleHumansPre-EclampsiaPregnancyRiskTime FactorsConceptsOral contraceptivesOral contraceptionRisk factorsIncidence of preeclampsiaDevelopment of hypertensionMajor medical centersOverall incidenceEarly pregnancyMedical CenterPreeclampsiaMaternal factorsHypertensionContraceptivesMonthsMonth periodWomenPregnancyContraceptionIncidencePossible relationshipRecent useFactors
1980
The amylase/creatinine clearance ratio in normal pregnancy and pregnancies complicated by pancreatitis, hyperemesis gravidarum, and toxemia
DeVore G, Bracken M, Berkowitz R. The amylase/creatinine clearance ratio in normal pregnancy and pregnancies complicated by pancreatitis, hyperemesis gravidarum, and toxemia. American Journal Of Obstetrics And Gynecology 1980, 136: 747-754. PMID: 6153508, DOI: 10.1016/0002-9378(80)90451-2.Peer-Reviewed Original ResearchConceptsHyperemesis gravidarumEpigastric painClinical diagnosisAmylase/creatinine clearance ratioCreatinine clearance ratioDiagnosis of pancreatitisCaM/Pregnant patientsCreatinine clearanceNonpregnant patientsNonpregnant valuesNormal pregnancyPancreatitisPatientsPregnancyToxemiaGravidarumElevated ratioDiagnosisClearance ratioPainGestationClearance